About Accel Diagnostics
Accel Diagnostics is a company based in Pittsburgh (United States) founded in 2012. Accel Diagnostics has raised $950 thousand across 4 funding rounds from investors including Innovation Works, Swartz Center for Entrepreneurship at Carnegie Mellon University and AlphaLab. Accel Diagnostics offers products and services including COVID-19 Tests, Urine Drug Tests, Wellness Panels, STD Panels, and General Health Tests. Accel Diagnostics operates in a competitive market with competitors including ACXEL, Axbio, SpacePharma, Micronit and NanoEntek, among others.
- Headquarter Pittsburgh, United States
- SectorsHealthcare
- Website acceldx.com
- Social LinkedIn X
- Total Equity Funding$950K (USD)
in 4 rounds
- Latest Funding Round$200K (USD), Seed
Apr 2013
- InvestorsInnovation Works
& 2 more
Products & Services of Accel Diagnostics
Accel Diagnostics offers a comprehensive portfolio of products and services, including COVID-19 Tests, Urine Drug Tests, Wellness Panels, STD Panels, and General Health Tests.
Provides RT-PCR and antigen tests for COVID-19 detection and travel needs.
Offers panels for detecting various substances in urine samples.
Includes annual check-ups for liver, kidney, and thyroid functions.
Detects common sexually transmitted infections for early treatment.
Covers blood counts, lipid panels, and hormone tests for overall health.
Funding Insights of Accel Diagnostics
Accel Diagnostics has successfully raised a total of $950K across 4 strategic funding rounds. The most recent funding activity was a Seed round of $200 thousand completed in April 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $950,000
- Total Rounds 4
- Last Round Seed — $200,000
- First Round $25,000
(Feb 2012)
- Investors Count 3
All 4 funding rounds of Accel Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2013 | $200,000 | Seed | – | – | |
| Sep 2012 | $625,000 | Angel Round | – | – | – |
| Jun 2012 | $100,000 | Seed | – | – | |
| Feb 2012 | $25,000 | Seed | – | – |
3 investors in total: 3 institutional.
Investors in Accel Diagnostics
Accel Diagnostics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Innovation Works, Swartz Center for Entrepreneurship at Carnegie Mellon University and AlphaLab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Accelerator programs supporting startups in technology sectors, including software and robotics, in Pittsburgh. | – | alphalab.org | - | |
Software, hardware, and life sciences startups are funded and accelerated. | 1999 | innovationworks.org | Pittsburgh, United States | |
- | – | cmu.edu/open-field | - |
Investor details for Accel Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Accel Diagnostics
1 people are tracked at Accel Diagnostics (1 in leadership).
| Name | Role | Group |
|---|---|---|
Alberto Gandini | CEO/Cofounder | Leadership |
Complete people profiles for Accel Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Accel Diagnostics
3 dated milestones of Accel Diagnostics across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Accel Diagnostics is founded.
- Funding First funding round of $25K.
- Funding Latest funding round, Seed, of $200K.
Competitors of Accel Diagnostics
Accel Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ACXEL, Axbio, SpacePharma, Micronit and NanoEntek, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| acxel.com | 2016 | Foshan, China | – | – | Microfluidic technology and solutions are provided for life sciences industries. | |
| axbio.cn | 2016 | Shenzhen, China | $200M | – | Developer of a lab on chip microfluidic platform for sequencing and molecular diagnostics using AI | |
| spacepharma.health | 2012 | Herzliya, Israel | $5M | – | Microgravity research solutions are provided for researchers and companies. | |
| micronit.com | 1999 | Enschede, Netherlands | – | 13 | Microfluidic devices and lab-on-chip solutions are designed and manufactured. | |
| nanoentek.com | 2000 | Seoul, South Korea | – | – | Point-of-care instruments for diagnostics and research are developed. | |
| finnadvance.com | 2018 | Oulu, Finland | $1.9M | – | Microfluidics and microtechnology solutions are developed for drug permeability testing. | |
| alveolix.com | 2015 | Bern, Switzerland | – | – | Developer of organ-on-chip technologies to enable more efficient drug development | |
| noul.com | 2015 | – | – | – | An AI-based digital microscope platform is used for blood analysis. | |
| akso-biotech.com | 2021 | Suzhou, China | – | – | Developer of microfluidic chip and technology for life science research |
Detailed competitors of Accel Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Accel Diagnostics
Websites that share an audience with Accel Diagnostics (acceldx.com).
Websites whose visitors overlap most with Accel Diagnostics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
acupath.com | acupath.com | 100% | – | #3,735,601 | – |
| moleculartestinglabs.com | 97% | – | #3,489,781 | View details | |
totalurologycare.com | totalurologycare.com | 23% | – | #2,071,489 | – |
pclabsdx.com | pclabsdx.com | 22% | – | #8,338,144 | – |
Similar companies to Accel Diagnostics
10 companies that operate in the same segment as Accel Diagnostics (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Accel Diagnostics
Accel Diagnostics was founded in 2012.
Accel Diagnostics is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Accel Diagnostics is a funded company, having raised a total of $950K across 4 funding rounds to date. The company's 1st funding round was a Seed of $25K, raised on Feb 2012.
Accel Diagnostics (AccelDx) is a medical technology company. Its product pScreen is a finger-prick blood test for the diagnosis, monitoring and management of a wide variety of diseases and medical conditions, including heart failure, cancer, womens health and infectious diseases. Users apply a small drop of body fluid (e.g., finger prick blood, urine) onto the pScreen. In less than 20 minutes, pScreen allows them to monitor and track the level of proteins (biomarkers) that map the health risk of the patient. It enables patients to monitor and effectively manage the progression of their chronic diseases. Users can scan the pScreen card with their smartphone to communicate the results to their healthcare provider.
Accel Diagnostics's top competitors include Noul, Suzhou Akso Biotechnology and Axbio.
Accel Diagnostics offers COVID-19 Tests, Urine Drug Tests, Wellness Panels, STD Panels, and General Health Tests.
Accel Diagnostics has 3 investors. Key investors include Innovation Works, Swartz Center for Entrepreneurship at Carnegie Mellon University, and AlphaLab.